Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Lifestyle changes can significantly improve hair loss in overweight women with PCOS.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Changes in skin bacteria can affect hair loss and new treatments targeting these bacteria may prevent balding without sexual side effects.

Different hair disorders have specific treatments and outcomes, with some resolving on their own and others requiring medication or emotional support.

Athletes need effective management of skin disorders for their performance and well-being.

DHT reduces a cell's ability to promote hair growth, while 3D culture without DHT improves it.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

A postmenopausal woman's facial redness, acne, and excess hair were caused by too much hormone therapy for insomnia, but improved after stopping the treatment.

Testosterone therapy can help with androgen deficiency in women but should be used with caution and monitoring due to potential risks.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The document concludes that accurate diagnosis and understanding the type of hair disorder are crucial for treating hair loss in children.

Androgen lowering medications don't significantly change HCV-related liver cancer risk in men.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Women with myotonic dystrophy might get diseases related to male hormones because their body tissues are extra sensitive to these hormones.

Higher androgen levels are linked to more severe hair growth in hirsute women.

The Free Androgen Index (FAI) is the best indicator of early hair loss in men before age 30.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

A specific genetic mutation may increase male pattern baldness risk, especially in Europeans.

Mutations in the androgen receptor gene cause Androgen Insensitivity Syndrome, affecting sexual development.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

The length of CAG repeats in the androgen receptor gene is linked to ovarian reserve but does not affect how the ovaries respond to stimulation.